These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9314914)

  • 1. Circulating nitric oxide levels in galactorrheic, hyperprolactinemic, amenorrheic women.
    Shaarawy M; Nafei S; Abul-Nasr A; el-Sharkawy S; Younis A
    Fertil Steril; 1997 Sep; 68(3):454-9. PubMed ID: 9314914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
    Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
    J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women.
    Shaarawy M; El-Dawakhly AS; Mosaad M; El-Sadek MM
    Clin Chem Lab Med; 1999 Apr; 37(4):433-8. PubMed ID: 10369115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin levels in postpill amenorrheic patients.
    Karaman AS; Uran B; Erler A
    Int J Gynaecol Obstet; 1993 Nov; 43(2):177-80. PubMed ID: 7905434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
    Elkind-Hirsch KE; Platia MP; Schiff I
    J Reprod Med; 1987 Jan; 32(1):5-9. PubMed ID: 3550065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
    Giusti M; Fazzuoli L; Cavallero D; Valenti S
    Gynecol Endocrinol; 2002 Oct; 16(5):407-12. PubMed ID: 12587536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between hyperprolactinemia and galactorrhea].
    Romero Gutierrez G; Aguirre Beltran AF; Figueroa Solana MI; Malacara Hernandez JM
    Ginecol Obstet Mex; 1989 Nov; 57():294-7. PubMed ID: 2486966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased spinal mineral content in amenorrheic women.
    Cann CE; Martin MC; Genant HK; Jaffe RB
    JAMA; 1984 Feb; 251(5):626-9. PubMed ID: 6690836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatographic pattern of circulating prolactin in ovulatory hyperprolactinemia.
    Andino NA; Bidot C; Valdés M; Machado AJ
    Fertil Steril; 1985 Nov; 44(5):600-5. PubMed ID: 3932101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood's enuresis in the history of women with hyperprolactinemic amenorrhea.
    Fava M; Guaraldi GP; Borofsky GL; Mastrogiacomo I
    Int J Psychiatry Med; 1989; 19(1):41-6. PubMed ID: 2722404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial aspects of hyperprolactinemia.
    Assies J; Vingerhoets AJ; Poppelaars K
    Psychoneuroendocrinology; 1992 Nov; 17(6):673-9. PubMed ID: 1287685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prolactin, gonadotropins, and estradiol in menstruating and amenorrheic mothers during two years' lactation.
    Delvoye P; Demaegd M; Uwayitu-Nyampeta ; Robyn C
    Am J Obstet Gynecol; 1978 Mar; 130(6):635-9. PubMed ID: 637075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin.
    Matsuzaki T; Azuma K; Irahara M; Yasui T; Aono T
    Fertil Steril; 1994 Dec; 62(6):1143-9. PubMed ID: 7957976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin modulation of dehydroepiandrosterone sulfate secretion.
    Lobo RA; Kletzky OA; Kaptein EM; Goebelsmann U
    Am J Obstet Gynecol; 1980 Nov; 138(6):632-6. PubMed ID: 6449151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
    Klibanski A; Greenspan SL
    N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.